Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,483.50
+22.181.52%
Number of Gainers:6
Number of Losers:1
Number of Flat:- -
PE:- -
High:1,492.78
Open:1,460.48
Low:1,435.21
Close:1,461.32
Volume:149.45M
Turnover:11.26B
Market Cap:1.54T
Float Cap:1.49T

Loading ...

Option traders moderately bearish in Novo Nordisk with shares down 16.61%

TIPRANKS
·
1 hour ago

Novo Nordisk (0QIU) was downgraded to a Hold Rating at Deutsche Bank

TIPRANKS
·
1 hour ago

Assessing Novo Nordisk (NYSE:NVO) Valuation After Share Price Pullback And GLP 1 Growth Prospects

Simply Wall St.
·
1 hour ago

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
4 hours ago

Viking Therapeutics rises 10.7%

TIPRANKS
·
4 hours ago

Eli Lilly call volume above normal and directionally bullish

TIPRANKS
·
4 hours ago

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

Reuters
·
4 hours ago

Hedge Funds' Mag 7, Eli Lilly Buying Spree Sparks Massive ETF Accumulation In IVV, SPY, QQQ

Benzinga_recent_news
·
4 hours ago

Analysts: Novo Nordisk's CagriSema Setback May Shift Investor Focus to M&A Strategy

Deep News
·
4 hours ago

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
5 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-Enhabit, Ethos Technologies, gold miners

Reuters
·
5 hours ago

Novo Nordisk Stock Falls After Disappointing Drug Trial Results, but Is It a Buy Now? BofA Weighs In

TIPRANKS
·
Yesterday

Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week

Benzinga_recent_news
·
Yesterday

Novo Nordisk falls -14.7%

TIPRANKS
·
Yesterday

Pfizer CEO Albert Bourla to Speak at TD Cowen 46th Annual Health Care Conference Webcast

Reuters
·
Yesterday

Eli Lilly and Co Stock Opened Up by 3.36% on Feb 23: What Investors Need To Know

TradingKey
·
Yesterday

Unusually active option classes on open February 23rd

TIPRANKS
·
Yesterday

INSTANT VIEW-Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say

Reuters
·
Yesterday

Eli Lilly Introduces New Zepbound Formulation with Single Pen for Monthly Dosage

Deep News
·
Yesterday

FDA approves Zepbound label expansion to include multi-dose KwikPen

Reuters
·
Yesterday